IMMUTOL
41st Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) was held between September 24th–26th in Barcelona, Spain. IMMUTOL was represented by team members from the Institut de…
read more
The paper recently published in the British Journal of Clinical Pharmacology is entitled: Early-stage health technology assessment of a curative gene therapy for multiple sclerosis. Link to the article: http://doi.org/10.1002/bcp.70204 As indicated in the paper…
read more
EMSP is the umbrella organization for national Multiple Sclerosis (MS) organizations in Europe and has been the leading voice for people with MS for over 30 years. EMSP works with members, partners, and…
read more
The 2nd Annual Meeting of IMMUTOL consortium took place in Budapest between the 27th and 28th of May, 2025 hosted by SRI and organised by INN-Acta. The first day of the event was…
read more
SAVE THE DATE! IMMUTOL’s 2nd Annual Meeting will take place on May 27-28, 2025, at the Lion’s Garden Hotel in Budapest, Hungary.
read more
Luis Soria Jiménez, postdoctoral researcher and Ana María Barriocanal, MD, PhD joined the IMMUTOL projects from Institute de Investigacion en Ciencias de la Salut Germans Trias I Pujol. Welcome!
read more
Cristina Rosell, PhD recently joined the Immutol team from ASPHALION! Welcome!
read more
PhD student Alex Agúndez Moreno, from IGTP team, presented his work at the XVIII Congress of the Catalan Society of Immunology, held between 21st and 22nd November 2024 in Barcelona. The poster…
read more
IGTP team have an interview to the Badalona Comunicació newspaper. The article is entitled: ‘Fàrmacs combinats amb cèl·lules ‘reeducades’ in vitro, via de recerca per frenar l’avenç de l’esclerosi múltiple’…
read more